BIO Protocol is a leading protocol for the Desci (decentralized science) trend, aimed at promoting the development of biotechnology to improve human life. Recently, BIO was introduced by Binance as the 63rd project on the launchpool platform and will be listed on January 3, 2025.
1. What is BIO Protocol?
BIO Protocol is a management and liquidity protocol specifically designed for the Decentralized Science (DeSci) sector. Its mission is to foster the growth of biotechnology by connecting and empowering patient communities, scientists, and biotech professionals worldwide. Together, they can fund, build, and collectively own encrypted and transparently managed biotechnology projects and intellectual property (IP).
The team behind BIO Protocol includes the creators of Molecule, a platform for tokenizing early-stage biomedical research, and VitaDAO, the largest decentralized community focused on longevity science. Building upon these successes, BIO Protocol aims to establish a blockchain-based scientific economy through decentralized funding, incentive mechanisms, and liquidity for projects.
On December 23, 2024, Binance officially introduced BIO Protocol as the 63rd project on Binance Launchpool. Binance plans to list BIO tokens at 10:00 UTC on January 3, 2025.
Decentralized Science (DeSci) is a concept that integrates science and blockchain technology to create a transparent, equitable, and decentralized research ecosystem. DeSci leverages blockchain to facilitate open and transparent research funding, IP management, and content publishing.
This model transforms scientific research from a “black box” into an open space that encourages collaboration and innovation through collective intelligence. Since early 2023, DeSci has garnered significant attention, particularly after receiving investment from Binance Labs and the endorsement of Binance founder CZ.
2. Key Products of BIO Protocol
BIO Protocol introduces three strategic products: BIO Protocol (core infrastructure), BIO Launchpad (fundraising platform), and BioDAO Incubator (project incubation program).
2.1. BIO Protocol
BIO Protocol serves as the core infrastructure of the ecosystem, supporting on-chain economies for bioDAOs—decentralized scientific research communities.
Key features include:
IP Marketplace: A platform for buying and trading intellectual property assets.
Liquidity Systems: Facilitates efficient capital flow.
IP Management: Tools for ownership, licensing, and trading of IP assets.
How BioDAO operates:
BioDAOs raise funds by issuing tokens, which are then used to support biotech projects.
These projects create shared IP ownership among BioDAO members, leveraging Molecule’s on-chain IP framework for IP management, licensing, and trading.
Revenues from IP usage and related products flow back to BioDAO treasuries for reinvestment into next-generation R&D, advancing the mission of the organization.
Advantages of BioDAO over traditional research models:
Capital Efficiency: Shared resources reduce innovation costs.
Flexible Workforce: Experts can contribute part-time.
Shared IP Ownership: Encourages contributions through intellectual property benefits.
Open Access: Removes barriers in funding and decision-making.
Diversified Portfolios: Simultaneous projects mitigate risks.
2.2. BIO Launchpad
BIO Launchpad is a fundraising platform connecting investors with biotech projects, enabling BioDAOs to raise funds for research activities.
Operational model:
Investors: Commit funds and specify the maximum price they are willing to pay within a defined timeframe.
Projects: After auctions conclude, investors can claim tokens if selected.
Objectives:
Empower the BIO community to choose which DAOs to support and launch.
Provide initial funding and deep liquidity for projects post-launch.
Three phases of operation:
Governance: Evaluate and decide which projects qualify for BIO Protocol.
Acceleration: Mobilize funds from the community.
Separation: Launch projects on the open market with liquidity support.
2.3. BioDAO Incubator
BioDAO Incubator nurtures potential biotech projects that integrate blockchain technology and decentralized science research.
16-week program (hybrid online and offline):
Financial Support: Seed funding for project development.
Expert Guidance: Mentorship from biotech and blockchain specialists.
Technical Resources: Tools for building and operating BioDAOs effectively.
Goals:
Advance decentralized science.
Build public infrastructure for research.
Harness the potential of Web3, IP-NFTs, and tokenomics to drive innovation.
With an integrated ecosystem and clear strategy, BIO Protocol supports biotech projects while laying the foundation for a modern, transparent, and community-driven research system.
3. BIO Ecosystem
BIO Protocol’s ecosystem features prominent projects focusing on advanced scientific research, providing groundbreaking solutions for humanity:
VitaDAO: Pioneering longevity science.
AthenaDAO: Dedicated to women’s health.
PsyDAO: Integrating science and art to explore psychiatry.
ValleyDAO: Developing biotechnology to address environmental issues.
HairDAO: Offering solutions for hair loss.
CryoDAO: Innovating in cryopreservation.
CerebrumDAO: Researching brain health and preventing neurodegeneration.
Curetopia: Developing treatments for rare diseases.
Long Covid Labs: Addressing long COVID syndrome.
Quantum Biology DAO: Applying advanced electron microscopy to biological research.
4. Team
BIO Protocol boasts a team of experienced professionals combining expertise in blockchain and biotechnology:
Paul Kohlhaas – Founder & CEO: A DeSci pioneer, CEO of Molecule, and co-founder of VitaDAO, Paul previously held key roles at ConsenSys and contributed to blockchain solutions for the Swiss government before founding BIO Protocol.
Clemens Ortlepp – Co-founder & CPO: As BIO Protocol’s Chief Product Officer and co-founder of MTX Studio, Clemens has extensive experience in decentralized technologies. Previously, he served as Product Director at Molecule.
5. Investors
On November 8, 2024, BIO Protocol secured strategic investment from Binance Labs, a leading blockchain investment fund. Although the investment amount was undisclosed, this endorsement underscores Binance’s confidence in BIO Protocol’s potential.
6. Roadmap
Q4 2024:
Launch Testnet.
Integrate vBIO into the Solana ecosystem.
Q1 2025:
Official launch of BIO Protocol Launchpad.
Enable BIO token trading.
Support liquidity pairs on BIO’s platform.
Q2 2025:
Host the second community auction.
Release BIO Research Agents.
Q3 2025:
Introduce new BioDAOs.
7. Similar Projects
BIO Protocol is currently the leading project in the DeSci space.
8. BIO Token Overview
8.1. Basic Information
Token Name: BIO
Token Symbol: BIO
Blockchain: Ethereum
Smart Contract: 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA
Listing Date: January 3, 2025
Total Supply: 3,320,000,000 BIO
Circulating Supply: 1,296,529,168 BIO (39.05% of total supply)
8.2. BIO Token Allocation
BIO Tokens are allocated as follows:
Community (56%)
Community Auction (20%): 50% will be used for liquidity provision, while the remaining 50% unlocks gradually over 1 year.
Community Airdrop (6%): Rewards for holders of BioDAO tokens and early contributors to BIO Protocol. These tokens are locked for 1 year and then unlock over 6 years.
Ecosystem Incentives (25%): No locking mechanism applied.
Molecule Ecosystem Fund (5%): Unlocks gradually over 4 years.
Investors (13.6%)
Tokens are locked for 1 year and then unlock over 4 years.
Core Contributors (21.2%)
Tokens are locked for 1 year and then unlock over 6 years.
Advisors (4.2%)
Tokens are locked for 1 year and then unlock over 6 years.
Molecule (5%)
Unlocks gradually over 4 years.
8.3. BIO Token Unlock Schedule
The entire supply of BIO Tokens is expected to be fully unlocked within 7 years from the official listing date.
8.4. Applications of BIO Token
Governance and Decision-Making
BIO Token holders can participate in governing the BIO Protocol ecosystem.
Contribute to decisions regarding the selection, management, and operational rules of BioDAOs.
Financial Management
Vote on fund allocation, token issuance adjustments, and community incentive programs.
Ecosystem Incentives
Enjoy benefits and discounts when using health-related products and services from BioDAOs within the network.
8.5. Where to Buy BIO Tokens
Starting January 3, 2025, investors can buy and sell BIO on major exchanges like Binance.
9. Potential of BIO Protocol
9.1. Strengths
Pioneering DeSci (Decentralized Science)
A promising sector combining science, biotechnology, and blockchain.
Practical Products
Core products such as BIO Protocol (infrastructure layer), BIO Launchpad (fundraising platform), and BioDAO Incubator (project accelerator) provide high practical value.
Robust Ecosystem
Includes prominent BioDAOs like VitaDAO, AthenaDAO, and ValleyDAO, covering diverse fields from women’s health research and longevity to environmental conservation.
Experienced Team and Strong Backing
Led by professionals with deep expertise in blockchain and biotechnology. Backed by Binance and Binance Labs.
9.2. Risks and Challenges
New Field
DeSci is an emerging field requiring time and effort to gain traction in traditional scientific communities.
Potential Competition
Future entrants into the space may reduce BIO Protocol’s advantage.
Initial Large Supply
The large initial supply (3,320,000,000 BIO) and community allocation exceeding 50% could raise concerns about selling pressure.
Adoption Dependency
Success heavily relies on acceptance from researchers, the scientific community, and investors.
10. Conclusion
BIO Protocol is a promising project with potential to lead the DeSci sector, thanks to its innovative approach, outstanding team, and support from major investors. However, it faces significant challenges, particularly in driving adoption and managing token inflation pressure.
For investors, this project is worth considering for medium- to long-term investment, especially as the DeSci field expands and BIO Protocol maintains its pioneering position.